NATA Partners & Sponsors
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for whole blood and blood components collection and processing as well as for transfusion medicine and cell therapies. With its corporate philosophy of "caring for life", the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.
For more information, visit www.fresenius-kabi.com.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
Masimo Corporation is one of the world’s most admired medical technology companies credited with revolutionizing pulse oximetry and noninvasive patient monitoring. A global medical technology innovator, Masimo has been on the forefront of patient safety and a beacon of innovation in healthcare for more than 25 years. As the inventor of Measure-Through Motion and Low Perfusion Masimo SET® pulse oximetry—the market-leading pulse oximetry technology solution—and Masimo rainbow® Pulse CO-Oximetry™—a breakthrough noninvasive blood-constituent monitoring platform, Masimo has a portfolio of clinically proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. In addition, with technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe, Masimo’s advanced oximetry technologies can be found inside of today’s top multiparameter brands, such as Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs and Zoll, among others.
For more information, visit www.masimo.com.
Annual Symposium Sponsors
At Medtronic, we’re committed to Innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. To do that, we’re thinking beyond products and beyond the status quo – to continually find more ways to help people live better, longer. Medtronic CardioVascular is dedicated to developing therapies that address the unmet clinical needs of patients around the world. Our therapies combat the debilitating effects of coronary, peripheral, aortic and structural heart disease, enabling patients to live richer and fuller lives. For more information, visit www.medtronic.com.
The Nordic Group is a privately owned, fast growing, fully integrated, pan-European pharmaceutical company, with a strong focus on the development and commercialization of niche hospital and orphan products and services that cater to the specific needs of clients and patients. In addition to its direct sales and marketing presence in 17 European countries, operating under the name of Nordic Pharma and Nordic Drugs, the Nordic Group operates as well a number of specialized Pharmaceutical Services companies, specialized in product development, manufacturing, supply logistics, clinical studies and regulatory activities. Nordic (which was already marketing an aprotinin product) acquired rights to Trasylol® from Bayer in July 2012, worldwide excluding the United States. Additional information can be obtained at www.nordicpharmagroup.com.
SORIN GROUP is a global leader in the treatment of cardiovascular diseases. Committed to blood management for more than 30 years, and operating in more than 80 countries, Sorin Group has treated more than 6.5 million patients with its autotransfusion devices. At NATA, Sorin Group is proud to exhibit Sorin XTRA®, its sixth-generation autotransfusion system. Sorin XTRA® is a compact, ergonomic, robust autotransfusion device with an attractive design. Sorin XTRA® combines and improves the best features of current Sorin autotransfusion devices, introducing further innovation through C5 and S5-like design, graphic color touch screen user interface and advanced data management capabilities.
For more information, visit www.sorin.com.
Vifor Pharma is one of the world’s leaders in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-counter (OTC) products. Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global presence and a broad network of affiliates and partners around the world. The iron portfolio includes Ferinject® (ferric carboxymaltose), a novel intravenous iron replacement therapy, Venofer® (iron sucrose), the leading intravenous iron product for the treatment of iron deficiency anaemia in renal patients as well as the oral iron Maltofer®.
For more information, visit www.viforpharma.com.